Moreover, VCF2CNA predicted two additional MYCN amplification events among the remaining tumor samples, indicating that VCF2CNA can identify clinically relevant CNAs that were undetected by traditional methods of CNA detection. The gene discussed is MYCN; the disease is neoplasm.